152 related articles for article (PubMed ID: 37016248)
1. Intrathyroid thymic carcinoma: clinicopathological features and whole exome sequencing analysis.
Li J; Xiang R; Li Y; Liao Q; Liu Y
Virchows Arch; 2023 May; 482(5):813-822. PubMed ID: 37016248
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological Features of Intrathyroid Thymic Carcinoma].
Zheng ZG; Sun WY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):42-46. PubMed ID: 33663661
[TBL] [Abstract][Full Text] [Related]
3. Identification of Recurrent TERT Promoter Mutations in Intrathyroid Thymic Carcinomas.
Tahara I; Oishi N; Mochizuki K; Oyama T; Miyata K; Miyauchi A; Hirokawa M; Katoh R; Kondo T
Endocr Pathol; 2020 Sep; 31(3):274-282. PubMed ID: 32594366
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic characteristics of head and neck carcinoma showing thymus-like element].
Cui XJ; Zhang CY; Su P; Lyu B; Ren YB; Fan XS; Zhang XF; Wang Y; Song YH; Liu ZY
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):155-159. PubMed ID: 28297754
[No Abstract] [Full Text] [Related]
5. Intrathyroid thymic carcinoma: A clinicopathological analysis of 22 cases.
Gao Y; Pan Y; Luo Y; Cheng R; Zhai Q
Ann Diagn Pathol; 2023 Dec; 67():152221. PubMed ID: 37925863
[TBL] [Abstract][Full Text] [Related]
6. Whole exome sequencing and establishment of an organoid culture of the carcinoma showing thymus-like differentiation (CASTLE) of the parotid gland.
Ishikawa T; Ogawa T; Nakanome A; Yamauchi Y; Usubuchi H; Shiihara M; Yoshida T; Okamura Y; Kinoshita K; Katori Y; Furukawa T
Virchows Arch; 2021 Jun; 478(6):1149-1159. PubMed ID: 33415446
[TBL] [Abstract][Full Text] [Related]
7. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
Kuo TT; Chan JK
Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma.
Dorfman DM; Shahsafaei A; Miyauchi A
Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728
[TBL] [Abstract][Full Text] [Related]
9. [Thyroid carcinoma showing thymus-like differentiation: a clinicopathologic study of 8 cases].
Liu X; Hadeti B; Zhang W; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):89-93. PubMed ID: 21426803
[TBL] [Abstract][Full Text] [Related]
10. Intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) exhibits CD5 immunoreactivity: new evidence for thymic differentiation.
Dorfman DM; Shahsafaei A; Miyauchi A
Histopathology; 1998 Feb; 32(2):104-9. PubMed ID: 9543665
[TBL] [Abstract][Full Text] [Related]
11. Poorly Differentiated Nonkeratinizing Squamous Cell Carcinoma of the Thymus: Clinicopathologic and Molecular Genetic Study of 25 Cases.
Suster D; Pihan G; Mackinnon AC; Suster S
Am J Surg Pathol; 2018 Sep; 42(9):1224-1236. PubMed ID: 29975245
[TBL] [Abstract][Full Text] [Related]
12. Intrathyroid epithelial thymoma (ITET) and carcinoma showing thymus-like differentiation (CASTLE): CD5-positive neoplasms mimicking squamous cell carcinoma of the thyroid.
Kakudo K; Bai Y; Ozaki T; Homma K; Ito Y; Miyauchi A
Histol Histopathol; 2013 May; 28(5):543-56. PubMed ID: 23233417
[TBL] [Abstract][Full Text] [Related]
13. Intrathyroidal epithelial thymoma/carcinoma showing thymus-like differentiation; comparison with thymic lymphoepithelioma-like carcinoma and a possibility of development from a multipotential stem cell.
Hirokawa M; Miyauchi A; Minato H; Yokoyama S; Kuma S; Kojima M
APMIS; 2013 Jun; 121(6):523-30. PubMed ID: 23176314
[TBL] [Abstract][Full Text] [Related]
14. Absence of gene mutations in KIT-positive thymic epithelial tumors.
Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
[TBL] [Abstract][Full Text] [Related]
15. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
Pan CC; Chen PC; Chou TY; Chiang H
Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.
Nonaka D; Henley JD; Chiriboga L; Yee H
Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270
[TBL] [Abstract][Full Text] [Related]
17. Intrathyroidal Thymic Carcinoma: A Retrospective Case Series Study.
Liang J; Huang M; Huang H; Li L; Luo H; Mao W; Gao S; Xu H
Ear Nose Throat J; 2023 Sep; 102(9):584-589. PubMed ID: 36408572
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.
Su XY; Wang WY; Li JN; Liao DY; Wu WL; Li GD
Int J Clin Exp Pathol; 2015; 8(5):5354-62. PubMed ID: 26191237
[TBL] [Abstract][Full Text] [Related]
19. Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: a large scale study of 1465 non-small cell lung cancer cases.
Kriegsmann M; Muley T; Harms A; Tavernar L; Goldmann T; Dienemann H; Herpel E; Warth A
Diagn Pathol; 2015 Dec; 10():210. PubMed ID: 26643918
[TBL] [Abstract][Full Text] [Related]
20. Primary thymic adenocarcinomas: a clinicopathological and immunohistochemical study of 16 cases with emphasis on the morphological spectrum of differentiation.
Kalhor N; Moran CA
Hum Pathol; 2018 Apr; 74():73-82. PubMed ID: 29339175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
